Nanotechnology Company, Nano Labs Corp., recently inked a new General Agreement with CIATEQ, AC, Advanced Technology Center, to build and market solutions and products based on the industrial application of nanotechnologies.
This strategic move by Nano Labs will bring in new development to the healthcare industry, and encourage Nano Labs' resources to develop projects, and manufacture and produce the company's proprietary nanotechnology prototypes and products.
As per the General Agreement, both organizations will supportively develop specific research and commercial product programs and projects, subject to specific agreements outlining the purpose, activities, ownership and general obligations of each party.
This agreement may also involve many other activities, such as advisory and consulting, scientific research, technological development, engineering projects, training, and evaluation of technologies.
“We are very excited to be working with this esteemed organization. CIATEQ has a long history of success. Their resources – both in terms of technology and human capital – will allow us all to accomplish great things together. Invention and innovation is at the heart of this partnership. So much of science today is collaboration. By opening up development, knowledge can flow in multiple directions and become extremely effective in tackling some of the great challenges facing the world today." explained Dr. Victor Castano, chief innovations officer at Nano Labs. "A cross-disciplinary, resource driven strategy with a common goal will allow us to achieve uncommon results. No one is as smart as all of us thinking and working together."
As per the sources, both organizations will hold on to the copyrights and their respective industrial property rights for any future partnerships, and will use them to plan any new ownership of copyright or industrial property rights generated, produced or resulting from the activities covered in the Specific Agreement(s).
In related news, Nano Labs Corp. has just presented the results of its biological diagnostic tests, which it obtained on a miniature biosensor for tuberculosis.